Hizal, M. Et Al. 2020. Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study). JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7 , 1583-1589.

Hizal, M., ŞENDUR, M. A. N., Yasar, H. A., Bir Yucel, K., Arslan, C., Ucar, G., ... Karakaya, S.(2020). Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study). JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1583-1589.

Hizal, Mutlu Et Al. "Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1583-1589, 2020

Hizal, Mutlu Et Al. "Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1583-1589, 2020

Hizal, M. Et Al. (2020) . "Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1583-1589.

@article{article, author={Mutlu Hizal Et Al. }, title={Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={1583-1589} }